The HBsAg transgene, but not the PML deletion, induced HCC and/or hepatocellular adenoma (HCA) and As2O3 treatment significantly increased hepatocyte death while decreasing HCC development only in PML+/+HBsAgtg/0 mice. Here, PML is linked to hepatocellular carcinoma.